Vigabatrin (All indications)

Study	Exclusion reasons	Rmk	Reference
Vajda b (Vigabatrin) (Epilepsy), 2024	same data already obtained by other studies	EXCLUDED: Partial overlapping with Battino 2024, no details on the period of exposure during pregnancy, and congenital malformations reported in Vajda 2019 (same number of exposed pregnancies).